Cardiovascular Biotherapeutics Inc Henderson, NV - 89012

Cardiovascular Biotherapeutics Inc is categorized under Biotherapeutics in Henderson, NV and active since 2010.

Cardiovascular Biotherapeutics Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biotherapeutics business, which does work in the BOTH market, and is classified as a Biotherapeutics, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Daniel Montano at the company’s single location by writing to 1700 West Horizon Ridge Parkway # 100, Henderson, Nevada NV 89012 or by phoning (702) 248-1174. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cardiovascular Biotherapeutics Inc
Contact Person: Daniel Montano
Address: 1700 West Horizon Ridge Parkway # 100, Henderson, Nevada 89012
Phone Number: (702) 248-1174
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Biotherapeutics
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Cardiovascular Biotherapeutics Inc was started in 2010 to provide professional Biotherapeutics under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Daniel Montano for inquiries that concern Cardiovascular Biotherapeutics Inc by calling the company number (702) 248-1174, as your correspondence is most welcome. Additionally, the physical location of the single location of Cardiovascular Biotherapeutics Inc can be found at the coordinates 36.011711,-115.062438 as well as the street address 1700 West Horizon Ridge Parkway # 100 in Henderson, Nevada 89012.

For its online presence, you may visit Cardiovascular Biotherapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.